CX Institutional
ACN icon

CX Institutional’s Accenture ACN Stock Holding History

CX Institutional’s Portfolio ACN Stock Details ACN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$805K Sell
4,389
-38,824
-90% -$6.56M 0.02% 369
2026
Q2 		$5.38M Buy
43,213
+11,899
+38% +$2.07M 0.16% 146
2026
Q1 		$6.21M Buy
31,314
+2,366
+8% +$551K 0.19% 127
2025
Q4 		$7.77M Buy
28,948
+6,517
+29% +$1.66M 0.23% 114
2025
Q3 		$5.53M Buy
22,431
+2,499
+13% +$652K 0.17% 142
2025
Q2 		$5.96M Buy
19,932
+2,937
+17% +$894K 0.21% 122
2025
Q1 		$5.3M Sell
16,995
-4,126
-20% -$1.46M 0.2% 117
2024
Q4 		$7.43M Buy
21,121
+2,281
+12% +$821K 0.3% 80
2024
Q3 		$6.66M Buy
18,840
+15,304
+433% +$5.03M 0.3% 88
2024
Q2 		$1.07M Buy
3,536
+270
+8% +$82.7K 0.05% 273
2024
Q1 		$1.13M Buy
3,266
+79
+2% +$28.8K 0.05% 266
2023
Q4 		$1.12M Sell
3,187
-98
-3% -$31.6K 0.06% 243
2023
Q3 		$1.01M Buy
3,285
+11
+0.3% +$3.47K 0.06% 252
2023
Q2 		$1.01M Buy
3,274
+570
+21% +$166K 0.05% 276
2023
Q1 		$773K Buy
2,704
+937
+53% +$255K 0.04% 313
2022
Q4 		$472K Buy
1,767
+375
+27% +$104K 0.03% 371
2022
Q3 		$358K Sell
1,392
-162
-10% -$46.8K 0.02% 372
2022
Q2 		$431K Sell
1,554
-170
-10% -$51.1K 0.03% 355
2022
Q1 		$581K Buy
1,724
+18
+1% +$6.07K 0.05% 258
2021
Q4 		$707K Buy
1,706
+65
+4% +$23.7K 0.06% 225
2021
Q3 		$525K Buy
1,641
+24
+1% +$7.81K 0.04% 255
2021
Q2 		$477K Buy
1,617
+208
+15% +$59.6K 0.04% 252
2021
Q1 		$390K Buy
1,409
+97
+7% +$25.1K 0.03% 240
2020
Q4 		$342K Buy
1,312
+183
+16% +$43.9K 0.03% 257
2020
Q3 		$255K Sell
1,129
-9,591
-89% -$2.2M 0.03% 244
2020
Q2 		$2.3M Buy
10,720
+1,923
+22% +$364K 0.3% 83
2020
Q1 		$1.44M Buy
8,797
+8,195
+1,361% +$1.58M 0.23% 97
2019
Q4 		$127K Sell
602
-13
-2% -$2.53K 0.02% 215
2019
Q3 		$118K Buy
615
+26
+4% +$5.03K 0.02% 234
2019
Q2 		$109K Buy
589
+119
+25% +$21.4K 0.02% 262
2019
Q1 		$83K Buy
+470
New +$73.8K 0.01% 291

Other funds holding ACN

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Value Partners Investments
Value Partners Investments Winnipeg, Manitoba, Canada $1.44B AUM 16.68% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

CX Institutional's ACN Position: Q3 2026 in Review

CX Institutional reduced its Accenture (ACN) stake by 90% in Q3 2026, selling an estimated $6.56M and leaving 4,389 shares worth $805K. The position accounts for 0.02% of the portfolio, ranked #369.

CX Institutional first reported a position in ACN in Q1 2019 and has held it in 31 quarters since. The position peaked at $7.77M in Q4 2025. 501 funds tracked by Wall St. Rank hold ACN as of Q3 2026.

  • CX Institutional held 4,389 shares of Accenture worth $805K as of Q3 2026.
  • CX Institutional sold 38,824 Accenture shares in Q3 2026, an estimated $6.56M.
  • Accenture made up 0.02% of CX Institutional's portfolio in Q3 2026, its #369 holding.
  • CX Institutional first reported a position in Accenture in Q1 2019 and has held it in 31 quarters since.
  • CX Institutional's Accenture position peaked at $7.77M in Q4 2025.
  • 501 funds tracked by Wall St. Rank held Accenture as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.